Leishmaniose cutanée au cours d'une polymyosite
暂无分享,去创建一个
H. Levesque | I. Marie | P. Courville | J. Bernet | L. Favennec | C. Fevre | H. Lévesque
[1] J. Berman,et al. Advances in leishmaniasis , 2005, The Lancet.
[2] J. Berman. Clinical status of agents being developed for leishmaniasis , 2005, Expert opinion on investigational drugs.
[3] J. Boyle,et al. Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis , 2005, The British journal of dermatology.
[4] Mae Uthman,et al. Clinical and histopathological features of zoonotic cutaneous leishmaniasis in Saudi Arabia , 2005, Journal of the European Academy of Dermatology and Venereology : JEADV.
[5] H. Günthard,et al. Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1. , 2005, Clinical Infectious Diseases.
[6] P. Couppié,et al. Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)‐infected patients and non‐HIV‐infected patients in French Guiana , 2004 .
[7] K. Makhoul,et al. Cutaneous leishmaniasis: recognition and treatment. , 2004, American family physician.
[8] N. Hepburn. Cutaneous leishmaniasis: current and future management , 2003, Expert review of anti-infective therapy.
[9] R. Pradinaud,et al. Leishmania and HIV co-infection: dermatological manifestations , 2003, Annals of tropical medicine and parasitology.
[10] R. Peto,et al. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran. , 2003, Bulletin of the World Health Organization.
[11] J. Maguire,et al. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. , 2002, The New England journal of medicine.
[12] G. Marshall,et al. Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[13] I. Ocaña,et al. Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients. , 1996, The American journal of medicine.
[14] C. Hennequin,et al. Cutaneous leishmaniasis in an AIDS patient: cure with itraconazole. , 1990, The Journal of infectious diseases.
[15] R. Paredes,et al. Leishmaniasis in HIV infection. , 2003, Journal of postgraduate medicine.